$2.01
-0.18[-8.22%]
At close: May 17
$2.01
0[0.00%]
After Hours: 7:59PM EDT
Pacific Biosciences
(NASDAQ:PACB)Pacific Biosciences Stock (NASDAQ:PACB), Quotes and News Summary
Pacific Biosciences Stock (NASDAQ: PACB) stock price, news, charts, stock research, profile.
| Open | $2.170 |
| Close | $2.020 |
| Volume / Avg. | 8.138M / 11.119M |
| Day Range | 2.000 - 2.190 |
| 52 Wk Range | 1.250 - 14.550 |
| Market Cap | $547.435M |
| P/E Ratio | - |
| Dividend Yield | - |
| Exchange | NASDAQ |
| RSI | 46 |
| Short Interest | 22.34% |
| Days to Cover | 2.88 |
Financials
Quarterly
Annual
| Name |
|---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Pacific Biosciences (PACB) stock?
You can purchase shares of Pacific Biosciences (NASDAQ: PACB) through any online brokerage.
Who are Pacific Biosciences's (PACB) competitors?
Other companies in Pacific Biosciences’s space includes: Harvard Bioscience (NASDAQ:HBIO), Codexis (NASDAQ:CDXS), BioLife Solns (NASDAQ:BLFS), Lifecore Biomedical (NASDAQ:LFCR) and Olink Holding (NASDAQ:OLK).
What is the target price for Pacific Biosciences (PACB) stock?
The latest price target for Pacific Biosciences (NASDAQ: PACB) was reported by Morgan Stanley on Wednesday, May 15, 2024. The analyst firm set a price target for 4.00 expecting PACB to rise to within 12 months (a possible 99.00% upside). 29 analyst firms have reported ratings in the last year.
Current Stock Price for Pacific Biosciences (PACB)?
The stock price for Pacific Biosciences (NASDAQ: PACB) is $2.01 last updated May 17, 2024 at 7:59 PM EDT.
Does Pacific Biosciences (PACB) pay a dividend?
There are no upcoming dividends for Pacific Biosciences.
When is Pacific Biosciences (NASDAQ:PACB) reporting earnings?
Pacific Biosciences’s Q2 earnings are confirmed for Wednesday, July 31, 2024.
Is Pacific Biosciences (PACB) going to split?
There is no upcoming split for Pacific Biosciences.
What sector and industry does Pacific Biosciences (PACB) operate in?
Pacific Biosciences is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.